Eagle Harbor Asset Management’s AbbVie ABBV Stock Holding History

Eagle Harbor Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$614K	Hold	2,441	–	–	0.48%	60
2026 Q1	$531K	Sell	2,441 -422	-15%	-$93.6K	0.45%	70
2025 Q4	$654K	Sell	2,863 -127	-4%	-$28.9K	0.54%	55
2025 Q3	$692K	Hold	2,990	–	–	0.6%	52
2025 Q2	$555K	Hold	2,990	–	–	0.54%	60
2025 Q1	$626K	Sell	2,990 -133	-4%	-$25.9K	0.64%	53
2024 Q4	$555K	Hold	3,123	–	–	0.56%	56
2024 Q3	$617K	Hold	3,123	–	–	0.61%	51
2024 Q2	$536K	Hold	3,123	–	–	0.57%	58
2024 Q1	$569K	Sell	3,123 -682	-18%	-$118K	0.6%	55
2023 Q4	$590K	Sell	3,805 -51	-1%	-$7.43K	0.68%	49
2023 Q3	$575K	Sell	3,856 -398	-9%	-$58.4K	0.75%	40
2023 Q2	$573K	Sell	4,254 -800	-16%	-$117K	0.75%	44
2023 Q1	$805K	Sell	5,054 -443	-8%	-$67.7K	1.09%	27
2022 Q4	$888K	Sell	5,497 -2,009	-27%	-$308K	1.3%	24
2022 Q3	$1.01M	Sell	7,506 -1,578	-17%	-$226K	1.73%	15
2022 Q2	$1.39M	Buy	9,084 +137	+2%	+$20.9K	2.15%	9
2022 Q1	$1.45M	Sell	8,947 -200	-2%	-$29.1K	1.88%	11
2021 Q4	$1.24M	Buy	+9,147	New	+$1.08M	1.63%	11

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Eagle Harbor Asset Management's ABBV Position: Q2 2026 in Review

Eagle Harbor Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 2,441 shares worth $614K. The position accounts for 0.48% of the portfolio, ranked #60.

Eagle Harbor Asset Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.45M in Q1 2022. 4,180 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Eagle Harbor Asset Management held 2,441 shares of AbbVie worth $614K as of Q2 2026.
Eagle Harbor Asset Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.48% of Eagle Harbor Asset Management's portfolio in Q2 2026, its #60 holding.
Eagle Harbor Asset Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
Eagle Harbor Asset Management's AbbVie position peaked at $1.45M in Q1 2022.
4,180 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Eagle Harbor Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.